Artificial Intelligence-assisted Glaucoma Screening (AIAGS)

Glaucoma Eye Clinical Trial

Official title:

The Development of Artificial Intelligence-assisted Glaucoma Screening Program

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03682783
• Other study ID #: 81300776
• Status: Not yet recruiting
• Start date: October 1, 2018
• Est. completion date: October 30, 2021

Study information

• Verified date: September 2018
• Source: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
• Contact: Haiyan Wang, Ph.D.
• Phone: +86 15000096256
• Email: catherinecnc81[@]126.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study will develop an artificial intelligence (AI) program for the screening of glaucoma.

Description:

We have realized that the glaucomatous optic neuropathy is irreversible. But if early detection and early intervention can be performed to control the development of the disease, it can greatly reduce the blindness rate of glaucoma, improve the life quality and physiological and mental health of patients, and alleviate the social burden. Therefore, screening and early diagnosis of glaucoma is the focus of glaucoma prevention.

China has a population of 1.3 billion, which greatly increase the difficulty of disease screening. In recent years, the intersection of artificial intelligence (AI) technology and modern medicine has made efficient and rapid disease screening possible.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 8000
• Est. completion date: October 30, 2021
• Est. primary completion date: October 1, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• able to complete fundus images

Exclusion Criteria:

• unable to complete fundus images

Related Conditions & MeSH terms

• Glaucoma
• Glaucoma Eye

Intervention

Diagnostic Test:
• Fundus Image
Fundus image of optic nerve

Locations

Country	Name	City	State
China	Shanghai General Hospital	Shanghai	Shanghai

Sponsors (1)

Lead Sponsor	Collaborator
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The specificity of the algorithm for diagnosing glaucoma	The specificity of the algorithm for diagnosing glaucoma will be calculated ...	from January 2020 to March 2021
Primary	The sensitivity of the algorithm for diagnosing glaucoma	The sensitivity of the algorithm for diagnosing glaucoma will be calculated .	from January 2020 to March 2021